Myles Gray injected testosterone, doctor tells hearing into police-involved death

At a public hearing into his 2015 death, Myles Gray's family doctor said Gray had been injecting unprescribed testosterone and had bipolar disorder; officers involved have denied misconduct and a 2023 coroner's jury classified the death as a homicide.

A public hearing in British Columbia is examining the 2015 police encounter that led to Myles Gray's death. His family doctor testified that Gray had been injecting unprescribed testosterone and that he had a diagnosis of bipolar disorder. The hearing follows a 2023 coroner's jury finding that classified the death as a homicide and was sought by Gray's family after a discipline authority cleared seven officers in 2024. Key testimony: - Dr. Christoffel Mentz-Serfontein said Gray had used unprescribed "black market" testosterone, which raised his red blood cell count, and that he had warned Gray the injections could aggravate bipolar disorder and destabilize mood. - Officers and witnesses described a forceful physical encounter during the August 2015 arrest in which officers restrained Gray; the officers involved have denied misconduct. - A coroner's jury in 2023 classified Gray's death as a homicide; that classification does not itself assign legal fault. - Testimony included accounts of officers finding Gray not breathing and providing emergency care, and at least one officer is expected to continue testifying. Summary: The hearing is hearing medical evidence about unprescribed testosterone use alongside police accounts of the 2015 restraint. Officers involved continue to deny misconduct and the coroner's homicide finding remains part of the record. Testimony is continuing, with further witness evidence expected in upcoming sessions.